F at Eli Lilly and Company

Neuilly-sur-Seine, Ile-de-France, France

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Skills

Key technologies and capabilities for this role

RWEReal World EvidenceReal World DataRWDBibliographic SynthesisEpidemiologyClinical DataEconomic DataRegulatory WatchHAS ReportsGuidelines

Questions & Answers

Common questions about this position

What is the employment type for this internship?

This is a full-time internship position.

Is this internship remote or does it require office presence?

This information is not specified in the job description.

What qualifications are required for this internship?

The position is for a student in Master 2 Pharmacoépidémiologie or Epidémiologie clinique.

What are the company values at Eli Lilly?

The company values are excellence, respect des individus (respect for individuals), and intégrité (integrity).

What makes a strong candidate for this internship?

A strong candidate is a Master 2 student in Pharmacoépidémiologie or Epidémiologie clinique who can contribute expertise to the HO&RWE team activities.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free